Drug Shortage Report for MYLERAN
| Report ID | 47182 |
| Drug Identification Number | 00004618 |
| Brand name | MYLERAN |
| Common or Proper name | Myleran |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | BUSULFAN |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 25 tablets |
| ATC code | L01AB |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-04-25 |
| Estimated end date | |
| Actual end date | 2018-07-24 |
| Shortage status | Resolved |
| Updated date | 2018-07-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-07-25 | French | Compare |
| v4 | 2018-07-25 | English | Compare |
| v3 | 2018-04-26 | English | Compare |
| v2 | 2018-04-25 | French | Compare |
| v1 | 2018-04-25 | English | Compare |
Showing 1 to 5 of 5